This Article Full Text Full Text (PDF) Other Versions of this Article: IAI.00735-07v1 75/9/4629    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Capul, A. A. Articles by Beverley, S. M. Search for Related Content PubMed PubMed Citation Articles by Capul, A. A. Articles by Beverley, S. M.

 Previous Article  |  Next Article 

Infection and Immunity, September 2007, p. 4629-4637, Vol. 75, No. 9
0019-9567/07/$08.00+0     doi:10.1128/IAI.00735-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Comparisons of Mutants Lacking the Golgi UDP-Galactose or GDP-Mannose Transporters Establish that Phosphoglycans Are Important for Promastigote but Not Amastigote Virulence in Leishmania major

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110,¹ Department of Biochemistry, University of Kentucky Medical Center, Lexington, Kentucky 40536²

Received 31 May 2007/ Accepted 12 June 2007

Abundant surface Leishmania phosphoglycans (PGs) containing [Gal(ß1,4)Man(1-PO₄)]-derived repeating units are important at several points in the infectious cycle of this protozoan parasite. PG synthesis requires transport of activated nucleotide-sugar precursors from the cytoplasm to the Golgi apparatus. Correspondingly, null mutants of the L. major GDP-mannose transporter LPG2 lack PGs and are severely compromised in macrophage survival and induction of acute pathology in susceptible mice, yet they are able to persist indefinitely and induce protective immunity. However, lpg2^– L. mexicana amastigotes similarly lacking PGs but otherwise normal in known glycoconjugates remain able to induce acute pathology. To explore this further, we tested the infectivity of a new PG-null L. major mutant, which is inactivated in the two UDP-galactose transporter genes LPG5A and LPG5B. Surprisingly this mutant did not recapitulate the phenotype of L. major lpg2^–, instead resembling the L. major lipophosphoglycan-deficient lpg1^– mutant. Metacyclic lpg5A^–/lpg5B^– promastigotes showed strong defects in the initial steps of macrophage infection and survival. However, after a modest delay, the lpg5A^–/lpg5B^– mutant induced lesion pathology in infected mice, which thereafter progressed normally. Amastigotes recovered from these lesions were fully infective in mice and in macrophages despite the continued absence of PGs. This suggests that another LPG2-dependent metabolite is responsible for the L. major amastigote virulence defect, although further studies ruled out cytoplasmic mannans. These data thus resolve the distinct phenotypes seen among lpg2^– Leishmania species by emphasizing the role of glycoconjugates other than PGs in amastigote virulence, while providing further support for the role of PGs in metacyclic promastigote virulence.

Published ahead of print on 2 July 2007.

Editor: W. A. Petri, Jr.

This article has been cited by other articles:

• Scott, D. A., Hickerson, S. M., Vickers, T. J., Beverley, S. M. (2008). The Role of the Mitochondrial Glycine Cleavage Complex in the Metabolism and Virulence of the Protozoan Parasite Leishmania major. J. Biol. Chem. 283: 155-165 [Abstract] [Full Text]